These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 330747)

  • 1. Immunosuppression by spleen cells from Moloney leukemia. III. Evidence for a suppressor cell that is not the leukemic, virus-producing cell.
    Cerny J; Grinwich KD; Stiller RA
    J Immunol; 1977 Sep; 119(3):1097-101. PubMed ID: 330747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression by spleen cells from Moloney leukemia. Comparison of the suppressive effect on antibody response and on mitogen-induced response.
    Cerny J; Stiller RA
    J Immunol; 1975 Oct; 115(4):943-9. PubMed ID: 170339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific susceptibility of sensitized (memory) B cells to suppression and antigenic alteration by murine leukemia virus.
    Cerny J; Waner EB
    J Immunol; 1975 Feb; 114(2 Pt 1):571-80. PubMed ID: 164504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA; Mentzer SJ; Maizel SE
    Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
    Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
    J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
    Kirchner H; Chused TM; Herberman RB; Holden HT; Lavrin DH
    J Exp Med; 1974 Jun; 139(6):1473-87. PubMed ID: 4598016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of Moloney virus induced antigen on antibody-producing cells.
    Celada F; Asjö B; Klein G
    Clin Exp Immunol; 1970 Mar; 6(3):317-23. PubMed ID: 4909958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression of humoral immunity to sheep erythrocytes in vitro by Friend virus leukemic spleen cells: induction of resistance by statolon.
    Weislow OS; Wheelock EF
    J Immunol; 1975 Jan; 114(1 Pt 1):211-5. PubMed ID: 1089711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor specific antigen appearance on normal cells during intermediate steps of viral carcinogenesis.
    Celada F
    Boll Ist Sieroter Milan; 1971; 50(3):176-84. PubMed ID: 5169543
    [No Abstract]   [Full Text] [Related]  

  • 14. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic mechanisms in the pathogenesis of virus-induced leukemia. IV. Mechanism of target cell recognition by autoreactive thymocytes.
    Proffitt MR; Kozak C; de la Motte C; Caulfield MJ
    J Immunol; 1985 Jun; 134(6):4244-9. PubMed ID: 3872912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s).
    Lamon EW; Skurzak HM; Andersson B; Whitten HD; Klein E
    J Immunol; 1975 Apr; 114(4):1171-6. PubMed ID: 1117138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.
    Biasi G; Saggin L; Dazzi F; De Rossi A; Collavo D
    J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression by Moloney leukemia virus: lack of correlation between virus replication and the immunosuppressive effect.
    Cerny J; Proffitt MR; Essex M
    J Natl Cancer Inst; 1976 Apr; 56(4):819-22. PubMed ID: 768506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell interactions in leukemia-associated immunosuppression: suppression of thymus-independent antibody responses by leukemia spleen cells (Moloney) in vitro is mediated by normal T cells.
    Caulfield MJ; Cerny J
    J Immunol; 1980 Jan; 124(1):255-60. PubMed ID: 6965291
    [No Abstract]   [Full Text] [Related]  

  • 20. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell.
    Kiessling R; Klein E; Pross H; Wigzell H
    Eur J Immunol; 1975 Feb; 5(2):117-21. PubMed ID: 1086218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.